CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Biotech
Original article

Halozyme Therapeutics, Inc. Announces Proposed Offering of $1.05 Billion of Convertible Senior Notes due 2033

Neutral
AI Analysis

Summary

Halozyme Therapeutics announced a proposed offering of $1.05 billion in convertible senior notes due 2033, subject to market conditions. The offering is routine capital raising activity.

Importance:6/10
Sentiment:
0.00
convertible notesdebt offeringcapital raise
Related Companies

Read the original article

Published by PR Newswire Biotech on September 16, 2026 8:30 PM

Read Original